Accessibility: Skip TopNav
English
Danish
Novo Nordisk re-initiates phase 3 development of liraglutide for obesity
June 22, 2010 04:47 ET
| Source:
Novo Nordisk A/S
Novo Nordisk A/S
For release content, please refer to the attachment.
Attachments
Company Announcement no 32 2010...